IL96790A - History of A-nor-steroid-3-carboxylic acid - Google Patents

History of A-nor-steroid-3-carboxylic acid

Info

Publication number
IL96790A
IL96790A IL9679090A IL9679090A IL96790A IL 96790 A IL96790 A IL 96790A IL 9679090 A IL9679090 A IL 9679090A IL 9679090 A IL9679090 A IL 9679090A IL 96790 A IL96790 A IL 96790A
Authority
IL
Israel
Prior art keywords
compound
carboxylic acid
androst
ene
steroid
Prior art date
Application number
IL9679090A
Other languages
English (en)
Hebrew (he)
Other versions
IL96790A0 (en
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL96790A0 publication Critical patent/IL96790A0/xx
Publication of IL96790A publication Critical patent/IL96790A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J61/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by contraction of only one ring by one or two atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
IL9679090A 1989-12-29 1990-12-26 History of A-nor-steroid-3-carboxylic acid IL96790A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45886989A 1989-12-29 1989-12-29
US07/580,759 US5100917A (en) 1989-12-29 1990-09-11 Novel a-nor-steroid-3-carboxylic acid derivatives

Publications (2)

Publication Number Publication Date
IL96790A0 IL96790A0 (en) 1991-09-16
IL96790A true IL96790A (en) 1995-03-15

Family

ID=27039140

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9679090A IL96790A (en) 1989-12-29 1990-12-26 History of A-nor-steroid-3-carboxylic acid

Country Status (20)

Country Link
US (1) US5100917A (fi)
EP (1) EP0435321B1 (fi)
JP (1) JP3039996B2 (fi)
KR (3) KR0178468B1 (fi)
CN (4) CN1033809C (fi)
AT (1) ATE126232T1 (fi)
AU (1) AU634326B2 (fi)
CA (1) CA2033392C (fi)
DE (1) DE69021530T2 (fi)
DK (1) DK0435321T3 (fi)
ES (1) ES2078291T3 (fi)
FI (1) FI94418C (fi)
GR (1) GR3017559T3 (fi)
HU (1) HU210340B (fi)
IE (1) IE67511B1 (fi)
IL (1) IL96790A (fi)
MX (1) MX9203338A (fi)
NO (1) NO180719C (fi)
NZ (1) NZ236589A (fi)
PT (1) PT96394B (fi)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2118222T3 (es) * 1991-12-20 1998-09-16 Glaxo Wellcome Inc Inhibidores de 5-alfa-testosterona reductasa.
UA35589C2 (uk) * 1992-05-21 2001-04-16 Андорешерш Інк. ІНГІБІТОРИ ТЕСТОСТЕРОН 5-<font face="Symbol">a</font>-РЕДУКТАЗИ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ТА СПОСІБ ІНГІБУВАННЯ АКТИВНОСТІ ТЕСТОСТЕРОН 5-<font face="Symbol">a</font>-РЕДУКТАЗИ
US5302589A (en) * 1992-08-07 1994-04-12 Glaxo, Inc. Heterocyclic inhibitors of 5-α-testosterone reductase
GB9224148D0 (en) * 1992-11-18 1993-01-06 Smithkline Beecham Corp Compounds
US5561124A (en) * 1992-11-18 1996-10-01 Webb; Robert L. 17-α-acyl steroids which inhibit 5-α-reductase
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
US5541322A (en) * 1994-10-14 1996-07-30 Glaxo Wellcome Inc. Synthesis of 6-azaandrostenones
US5543417A (en) * 1994-10-21 1996-08-06 Merck & Co., Inc. Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) * 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8119109B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
KR101108439B1 (ko) 2002-10-25 2012-01-31 포믹스 리미티드 화장료 및 약제용 거품제
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
FR2857968B1 (fr) * 2003-07-25 2006-02-03 Inovat Sarl Nouveaux derives steroides et leurs utilisations therapeuthique
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
WO2007039825A2 (en) * 2005-05-09 2007-04-12 Foamix Ltd. Saccharide foamable compositions
US20080152596A1 (en) * 2005-07-19 2008-06-26 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
EP2073794A2 (en) * 2006-11-14 2009-07-01 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
US20080260655A1 (en) * 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
AU2009205314A1 (en) * 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US8871184B2 (en) 2009-10-02 2014-10-28 Foamix Ltd. Topical tetracycline compositions
JP5527236B2 (ja) * 2011-01-31 2014-06-18 信越化学工業株式会社 ポジ型化学増幅レジスト材料、パターン形成方法及び酸分解性ケトエステル化合物
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3336338A (en) * 1963-09-13 1967-08-15 Squibb & Sons Inc A-nor-cholestatriene-21-oic acid 21->24 lactones
US3600425A (en) * 1963-09-13 1971-08-17 Squibb & Sons Inc Synthesis of steroids
US3484476A (en) * 1963-09-13 1969-12-16 Squibb & Sons Inc A-nor steroids
US3424751A (en) * 1965-10-20 1969-01-28 Du Pont Selected 2-formyl-and 2alpha-(cyanoamidino)-a-nor-5alpha-androstane derivatives
US3492359A (en) * 1966-01-14 1970-01-27 Squibb & Sons Inc 11,12-oxo and/or oxy substituted a-norpregnenes
US4910226A (en) * 1987-04-29 1990-03-20 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors

Also Published As

Publication number Publication date
HU210340B (en) 1995-03-28
CN1127257A (zh) 1996-07-24
DE69021530T2 (de) 1996-02-01
ATE126232T1 (de) 1995-08-15
IE904720A1 (en) 1991-07-17
DK0435321T3 (da) 1995-09-18
AU634326B2 (en) 1993-02-18
FI94418B (fi) 1995-05-31
DE69021530D1 (de) 1995-09-14
JPH04134094A (ja) 1992-05-07
HU908495D0 (en) 1991-07-29
FI906438A (fi) 1991-06-30
CA2033392C (en) 2002-08-27
KR0178468B1 (ko) 1999-04-01
PT96394A (pt) 1991-10-15
CN1036200C (zh) 1997-10-22
KR910011887A (ko) 1991-08-07
KR0178470B1 (ko) 1999-04-01
ES2078291T3 (es) 1995-12-16
EP0435321A3 (en) 1992-04-29
MX9203338A (es) 1992-09-01
NZ236589A (en) 1993-02-25
EP0435321B1 (en) 1995-08-09
FI94418C (fi) 1995-09-11
GR3017559T3 (en) 1995-12-31
CN1127256A (zh) 1996-07-24
CA2033392A1 (en) 1991-06-30
NO905608D0 (no) 1990-12-27
EP0435321A2 (en) 1991-07-03
US5100917A (en) 1992-03-31
CN1033809C (zh) 1997-01-15
NO180719B (no) 1997-02-24
CN1127258A (zh) 1996-07-24
NO905608L (no) 1991-07-01
CN1052866A (zh) 1991-07-10
PT96394B (pt) 1998-10-30
JP3039996B2 (ja) 2000-05-08
IE67511B1 (en) 1996-04-03
IL96790A0 (en) 1991-09-16
FI906438A0 (fi) 1990-12-28
HUT56379A (en) 1991-08-28
AU6844790A (en) 1991-07-04
KR0178471B1 (ko) 1999-04-01
NO180719C (no) 1997-06-04

Similar Documents

Publication Publication Date Title
EP0435321B1 (en) Novel A-nor-steroid-3-carboxylic acid derivatives
US4317817A (en) Novel steroid 5α-reductase inhibitors
AU4258493A (en) Inhibitors of testosterone 5alpha-reductase activity
JP3337689B2 (ja) 15−置換4−アザステロイド
JPH10507755A (ja) 7−置換4−アザコラン酸誘導体とその使用
US7071229B2 (en) Process for producing corosolic acid
JPS6323895A (ja) 新規な6−もしくは7−メチレンアンドロスタ−1,4−ジエン−3,17−ジオン誘導体およびその製造方法
US5219879A (en) Heterocyclic steroid compounds
HU210046B (en) Process for the preparation of 4-amino-delta 4-steroids and pharmaceutical compositions containing the same
HUT69408A (en) Androstane derivatives as antiandrogenes and pharmaceutical compositions containing them and intermediates
CA1140110A (fr) Procede de preparation de nouveaux derives de l&#39;androst-4-ene
CA1154008A (en) STEROID 5.alpha.-REDUCTASE INHIBITORS
EP0193871B1 (en) 2-oxa- or aza-pregnane compounds
EP0059146B1 (fr) Nouveaux médicaments dérivés de la 3-hydroxy dodécahydro benz (e) inden-7-one, produits dérivés de la 3-hydroxy dodécahydro benz (e) inden-7-one et leur procédé de préparation
US6413951B2 (en) 20-fluoro-17(20)-vinyl steroids
US3736317A (en) 2,2-dimethyl-6,7alpha-difluoromethylene-20-spirox-4-ene-3-ones or 3-ols and acyl esters thereof
FR2600254A1 (fr) Derives methylenes des androstene-4 diones-3, 17, leur procede de preparation, et leur application comme medicaments
EP0595990A1 (fr) Nouveaux steroides substitues en position 6 leurs procedes d&#39;obtention et des compositions pharmaceutiques en renfermant
AU2014233577A1 (en) Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives
CH498867A (fr) Procédé de préparation de dérivés stéroïdes insaturés substitués par un atome d&#39;oxygène endocyclique

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees